Clinical Trials Logo

Hypoxemia clinical trials

View clinical trials related to Hypoxemia.

Filter by:

NCT ID: NCT04772183 Recruiting - Respiratory Failure Clinical Trials

OxyGap : Comparison Between Different Pulse Oximeter and With the Arterial Blood Gase

OxyGap
Start date: March 24, 2021
Phase:
Study type: Observational

The oximeter is used to monitor intensive care patients undergoing oxygen therapy. It indicates pulsed oxygen saturation (SpO2), a reflection of arterial oxygen saturation (SaO2) which enables detection of hypoxemia and hyperoxia, both deleterious state. Current SpO2 recommendations aim to reduce both risk of hypoxemia and hyperoxia. SpO2 is considered the 5th vital sign. Current recommendations for SpO2 targets do not consider the variability of oximeters used in clinical practice. This variability and lack of specification represent an obstacle to an optimal practice of oxygen therapy. Thus, this study aims to compare the SpO2 values of different oximeters (Nonin, Masimo, Philips, Nellcor) used in clinical practice with the SaO2 reference value obtained by an arterial gas in order to specify the precision and the systematic biases of the oximeters studied. This data will also make it possible to refine the recommendations concerning optimal oxygenation

NCT ID: NCT04723017 Recruiting - Hypoxemia Clinical Trials

Perioperative Hypoxemia in Pediatrics

Start date: January 21, 2021
Phase:
Study type: Observational

The primary aim was to develop and validation of perioperative hypoxemia using clinical big data and deep learning technique in pediatric patients

NCT ID: NCT04435353 Recruiting - Clinical trials for Respiratory Distress Syndrome

Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19

Start date: March 22, 2020
Phase: N/A
Study type: Interventional

Vibroacoustic pulmonary therapy in patients with COVID19 is believed to have a positive effect on oxygen status and a decrease in the duration of respiratory failure

NCT ID: NCT04193878 Recruiting - Pneumonia Clinical Trials

ARrest RESpiraTory Failure From PNEUMONIA

ARREST
Start date: June 1, 2020
Phase: Phase 3
Study type: Interventional

This research study seeks to establish the effectiveness of a combination of an inhaled corticosteroid and a beta agonist compared to placebo for the prevention of acute respiratory failure (ARF) in hospitalized patients with pneumonia and hypoxemia.

NCT ID: NCT04170062 Recruiting - Clinical trials for Pulmonary Disease, Chronic Obstructive

Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest

Start date: December 15, 2020
Phase: N/A
Study type: Interventional

This study is meant to compare the amount of oxygen required for hypoxemia relief between current standard of care (oxygen only) and oxygen with the addition of high flow air for Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and Pulmonary Hypertension (PH) patients during rest. Subjects will be titrated from 0 L/min until they maintain 95% SpO2 for each of the following delivery methods: 1. Pulses of pure oxygen (control) 2. Constant high flow air with pulses of pure oxygen 3. Out of phase pulses of high flow air and pure oxygen

NCT ID: NCT04079465 Recruiting - Respiratory Failure Clinical Trials

Automated Oxygen Control by O2matic to Patients Admitted With Acute Hypoxemia

O2MATIC-ACUT
Start date: October 1, 2019
Phase: N/A
Study type: Interventional

The aim of this study is to examine if automated oxygen delivery with O2matic allows for faster weaning from oxygen supply and better oxygen control than manually controlled oxygen therapy for patients admitted to the emergency department with acute hypoxemia. Furthermore it will be tested if O2matic compared to manual control allows for earlier discharge.

NCT ID: NCT03969615 Recruiting - Clinical trials for Acute Respiratory Failure

SuperNO2VA™ and General Anesthesia Postoperative Care

Start date: October 15, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to randomly and prospectively evaluate the differences in outcomes between the control group (closed full facemask immediate post-extubation with standard oxygenating device used post-operatively in PACU) and the SuperNO2VA™ group (SuperNO2VA™ immediate post-extubation and post-operatively in PACU)

NCT ID: NCT03835741 Recruiting - COPD Exacerbation Clinical Trials

Automated Adjustment of Oxygen on Patient With Acute COPD Exacerbation - FreeO2 HypHop

FreeO2 HypHop
Start date: December 17, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate if automated adjustment of oxygen (with FreeO2 device) can reduce the hospital length of stay for acute exacerbation of COPD with comparison of manual oxygen titration.

NCT ID: NCT03802175 Recruiting - Hypoxemia Clinical Trials

The Application Of Lung Ultrasound In Postoperative Hypoxemia Patients

Start date: January 10, 2019
Phase:
Study type: Observational [Patient Registry]

Postoperative hypoxemia was persistent and common after surgery.Rapid diagnosis and subsequent therapeutic measures must be adopted by anesthesiologists.Lung ultrasound has been confirmed to be more sensitive and accurate for diagnosis of pulmonary ailment than chest radiography.The primary objective of the present study was to evaluate lung complications by bedside lung ultrasonography on patients suffered from hypoxemia after general anesthesia in the postoperative period.

NCT ID: NCT03750747 Recruiting - Hypoxemia Clinical Trials

Assessing the Feasibility and Effectiveness of Introducing Pulse Oximetry in IMCI Services

Start date: December 1, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the feasibility, acceptability and operational challenges of introducing Pulse Oximeter (PO) in IMCI services to manage acute respiratory infections at first-level primary care facilities in Bangladesh (phase 1). The investigators will also evaluate the effectiveness and cost-effectiveness of introducing PO in IMCI services at first level primary care health facilities (phase 2). This study will employ a cluster randomized controlled trial design to evaluate the effectiveness of introducing PO in IMCI services (phase-2 objective). The feasibility assessment (phase-1 objective) will be nested within the larger effectiveness trail as internal piloting; which will help in generating evidence for designing a robust phase-2 trial. First-level primary healthcare facilities providing IMCI services will be regarded as clusters and the unit of randomization. Sixteen first level primary care health facilities (UH&FWC) will be randomly assigned to comparison and intervention facilities.